Skip to main content
. 2023 May 9;13(2):279–291. doi: 10.1007/s44197-023-00106-3

Table 2.

The association of CCI components and severe COVID-19 in a multivariate logistic regression model

Diseases (Abbr. %) All COVID-19 cases (N = 20,320) Non-severe COVID-19 (N = 19,033) Severe COVID-19 (N = 1,287) OR (95% CI)* P-Value*
Myocardial infarction (MI, %) 663 (3.3%) 523 (2.7%) 140 (10.9%) 4.32 (3.55, 5.25)  < 0.001
Congestive heart-failure (CHF, %) 309 (1.5%) 208 (1.1%) 101 (7.8%) 7.71 (6.03, 9.85)  < 0.001
Peripheral vascular disease (PVD, %) 418 (2.1%) 303 (1.6%) 115 (8.9%) 6.07 (4.85, 7.58)  < 0.001
Cerebrovascular disease (CVD, %) 585 (2.9%) 434 (2.3%) 151 (11.7%) 5.70 (4.69, 6.92)  < 0.001
Dementia (%) 120 (0.6%) 79 (0.4%) 41 (3.2%) 7.85 (5.39, 11.56)  < 0.001
Chronic pulmonary disease (CPD, %) 2,040 (10.0%) 1,755 (9.2%) 285 (22.1%) 2.80 (2.43, 3.22)  < 0.001
Rheumatic diseases (Rh, %) 356 (1.8%) 289 (1.5%) 67 (5.2%) 3.56 (2.71, 4.68)  < 0.001
Peptic ulcer disease (PUD, %) 423 (2.1%) 361 (1.9%) 62 (4.8%) 2.62 (1.99, 3.45)  < 0.001
Mild liver disease (MLD, %) 326 (1.6%) 257 (1.4%) 69 (5.4%) 4.14 (3.15, 5.43)  < 0.001
Diabetes (DM, %) 1,149 (5.7%) 895 (4.7%) 254 (19.7%) 4.98 (4.28, 5.81)  < 0.001
Hemiplegia/Paraplegia 144 (0.7%) 103 (0.5%) 41 (3.2%) 6.05 (4.19, 8.72)  < 0.001
Moderate or severe renal disease (SRD, %) 356 (1.8%) 242 (1.3%) 114 (8.9%) 7.55 (5.99, 9.50)  < 0.001
Diabetes with end-organ damage (DMD, %) 115 (0.6%) 73 (0.4%) 42 (3.3%) 8.76 (5.97, 12.86)  < 0.001
Any malignant tumor (MT, %) 1,387 (6.8%) 1,214 (6.4%) 173 (13.4%) 2.28 (1.92, 2.70)  < 0.001
Moderate or severe liver disease (SLD, %) 46 (0.2%) 29 (0.2%) 17 (1.3%) 8.77 (4.81, 16.01)  < 0.001
Metastatic solid tumor (ST, %) 206 (1.0%) 175 (0.9%) 31 (2.4%) 2.66 (1.81, 3.91)  < 0.001
AIDS/HIV 11 (0.1%) 9 (0.0%) 2 (0.2%) 3.29 (0.71, 15.24) 0.128

Abbr Abbreviation, OR odds ratio, CI confidence interval

*P value and OR were estimated in the logistic regression model, adjusted for age, sex, income, and BMI